GGrantIndex
← Search

TOPOISOMERASE II POISONING AND ANTICANCER DRUG DESIGN

$220,640R01FY2001CANIH

University Of California San Diego, La Jolla CA

Investigators

Linked publications & trials

Abstract

Topoisomerases are nuclear enzymes that play an essential role in DNA metabolism and have emerged as the receptors for several clinically important anticancer agents. This proposal describes a research program directed toward the chemistry and biology of two classes of natural products that exhibit excellent antitumor activity by "poisoning" topoisomerase II. With a combination of bioorganic, computational and biological studies we aim to elucidate the mode of action of the above compounds and address issues pertaining to their structure-activity relationship. Research along these lines is expected to aid in the development of powerful and selective anticancer agents and could have important implications for cancer treatment.

View original record on NIH RePORTER →
TOPOISOMERASE II POISONING AND ANTICANCER DRUG DESIGN · GrantIndex